Published Date: 26 Apr 2023
One million Americans currently have Parkinson's disease, and another 90,000 are diagnosed with it each year. It is currently the second most prevalent neurodegenerative disease in the country. And it's moving up to No. 1. However, few people are familiar with Parkinson's.
Read Full NewsResearchers query parents of children with cancer and clinicians on barriers and facilitators to participation in clinical trials.
A deep learning system trained on whole-slide images classifies nine renal tumor subtypes with high accuracy and outperforms traditional grading in predicting patient outcomes.
1.
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
2.
Pollution exposure may affect lung cancer in women who have never smoked
3.
Healthy weight loss could lower your odds for cancer
4.
Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit
5.
FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting
1.
The Impact of Microadenoma on Hormonal Health
2.
The latest research on Thyroid Cancer: Symptoms, Diagnosis, and Treatment Options
3.
Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025
4.
Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained
5.
Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
Navigating the Complexities of Ph Negative ALL - Part VIII
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation